Literature DB >> 18604463

Complications of Tegress injections.

Eric A Hurtado, Rodney A Appell.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18604463     DOI: 10.1007/s00192-008-0674-z

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


× No keyword cloud information.
  3 in total

1.  The safety and efficacy of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in women with intrinsic urethral deficiency.

Authors:  Eric Hurtado; Rebecca McCrery; Rodney Appell
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-11-14

2.  Long-term results and patients' satisfaction after transurethral ethylene vinyl alcohol (Tegress) injections: a two-centre study.

Authors:  Annette Kuhn; Werner Stadlmayr; Amara Sohail; Ash Monga
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-10-23

3.  Complications of ethylene vinyl alcohol copolymer as an intraurethral bulking agent in men with stress urinary incontinence.

Authors:  Eric A Hurtado; Rebecca J McCrery; Rodney A Appell
Journal:  Urology       Date:  2008-02-15       Impact factor: 2.649

  3 in total
  3 in total

Review 1.  Urethral injection therapy for urinary incontinence in women.

Authors:  Vivienne Kirchin; Tobias Page; Phil E Keegan; Kofi Om Atiemo; June D Cody; Samuel McClinton; Patricia Aluko
Journal:  Cochrane Database Syst Rev       Date:  2017-07-25

Review 2.  Injectable biomaterials for the treatment of stress urinary incontinence: their potential and pitfalls as urethral bulking agents.

Authors:  Niall F Davis; F Kheradmand; T Creagh
Journal:  Int Urogynecol J       Date:  2012-12-08       Impact factor: 2.894

Review 3.  Regenerative medicine and injection therapies in stress urinary incontinence.

Authors:  Christopher J Hillary; Sabiniano Roman; Sheila MacNeil; Wilhelm K Aicher; Arnulf Stenzl; Christopher R Chapple
Journal:  Nat Rev Urol       Date:  2020-01-23       Impact factor: 14.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.